145 related articles for article (PubMed ID: 10813517)
1. Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography.
Berzas Nevado JJ; Villaseñor Llerena MJ; Contento Salcedo AM; Aguas Nuevo E
J Chromatogr Sci; 2000 May; 38(5):200-6. PubMed ID: 10813517
[TBL] [Abstract][Full Text] [Related]
2. Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study.
Berzas Nevado JJ; Villaseñor Llerena MJ; Guiberteau Cabanillas C; Rodríguez Robledo V; Buitrago S
J Sep Sci; 2006 Jan; 29(1):103-13. PubMed ID: 16485715
[TBL] [Abstract][Full Text] [Related]
3. Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine.
Starczewska B; Mielech K
J Pharm Biomed Anal; 2000 Aug; 23(2-3):243-7. PubMed ID: 10933516
[TBL] [Abstract][Full Text] [Related]
4. Assay validation for three antidepressants in pharmaceutical formulations: practical approach using capillary gas chromatography.
Nevado JJ; Llerena MJ; Salcedo AM; Nuevo EA
J Pharm Biomed Anal; 2005 Jun; 38(1):52-9. PubMed ID: 15907619
[TBL] [Abstract][Full Text] [Related]
5. Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
Buzinkaiová T; Polonský J
Electrophoresis; 2000 Aug; 21(14):2839-41. PubMed ID: 11001291
[TBL] [Abstract][Full Text] [Related]
6. Electroanalytical study of fluvoxamine.
Nouws HP; Delerue-Matos C; Barros AA; Rodrigues JA; Santos-Silva A
Anal Bioanal Chem; 2005 Aug; 382(7):1662-8. PubMed ID: 15983767
[TBL] [Abstract][Full Text] [Related]
7. Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine.
Starczewska B; Puzanowska-Tarasiewicz H; Baranowska K
J Pharm Biomed Anal; 2000 Aug; 23(2-3):477-81. PubMed ID: 10933541
[TBL] [Abstract][Full Text] [Related]
8. Micellar electrokinetic capillary chromatography for the determination of fluoxetine and its metabolite norfluoxetine in biological fluids.
Berzas Nevado JJ; Contento Salcedo AM; Villaseñor Llerena MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):261-8. PubMed ID: 11996492
[TBL] [Abstract][Full Text] [Related]
9. Analytical methodologies for the stereoselective determination of fluoxetine: An overview.
Hancu G; Cârcu-Dobrin M; Budău M; Rusu A
Biomed Chromatogr; 2018 Jan; 32(1):. PubMed ID: 28670837
[TBL] [Abstract][Full Text] [Related]
10. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
[TBL] [Abstract][Full Text] [Related]
11. Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.
Samanidou VF; Kourti PV
Bioanalysis; 2009 Aug; 1(5):905-17. PubMed ID: 21083062
[TBL] [Abstract][Full Text] [Related]
12. Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR.
Trefi S; Gilard V; Balayssac S; Malet-Martino M; Martino R
J Pharm Biomed Anal; 2008 Mar; 46(4):707-22. PubMed ID: 18206329
[TBL] [Abstract][Full Text] [Related]
13. A rapid electron-capture gas chromatographic method for the quantification of fluvoxamine in brain tissue.
Rotzinger S; Todd KG; Bourin M; Coutts RT; Baker GB
J Pharmacol Toxicol Methods; 1997 Apr; 37(3):129-33. PubMed ID: 9253748
[No Abstract] [Full Text] [Related]
14. Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.
Darwish IA
J AOAC Int; 2005; 88(1):38-45. PubMed ID: 15759724
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.
Eap CB; Gaillard N; Powell K; Baumann P
J Chromatogr B Biomed Appl; 1996 Jul; 682(2):265-72. PubMed ID: 8844419
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of Green and High-Throughput Microwell Spectrophotometric Assay for the Determination of Selective Serotonin Reuptake Inhibitors in Their Pharmaceutical Dosage Forms.
Darwish IA; Alzoman NZ
Molecules; 2023 May; 28(10):. PubMed ID: 37241961
[TBL] [Abstract][Full Text] [Related]
17. Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.
Johnson DJ; Sanderson H; Brain RA; Wilson CJ; Bestari KJ; Solomon KR
Regul Toxicol Pharmacol; 2005 Aug; 42(3):313-23. PubMed ID: 16024151
[TBL] [Abstract][Full Text] [Related]
18. A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.
Samanidou V; Pantazidou K; Kovatsi L; Njau S; Livanos A
J Sep Sci; 2012 Apr; 35(7):839-45. PubMed ID: 22532352
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry.
Weisskopf E; Panchaud A; Nguyen KA; Grosjean D; Hascoët JM; Csajka C; Eap CB; Ansermot N;
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1057():101-109. PubMed ID: 28511118
[TBL] [Abstract][Full Text] [Related]
20. Stability of fluoxetine in stored plasma, aqueous, and methanolic solutions determined by HPLC with UV detection.
Binsumait IA; Hadidi KA; Raghib SA
Pharmazie; 2001 Apr; 56(4):311-3. PubMed ID: 11338670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
